Overview

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Comparison among three different antithrombotic strategies after percutaneous LAA occlusion with a Watchman FLX LAAC device.
Phase:
Phase 4
Details
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Treatments:
Clopidogrel